MicroRNA-210 and its theranostic potential

19Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction: MicroRNAs (miRNAs) are a set of small single-stranded noncoding RNAs with diverse biological functions. As a prototypical hypoxamir, human microRNA-210 (hsa-miR-210) is one of the most widely studied miRNAs thus far. In addition to its involvement in sophisticated regulation of numerous biological processes, miR-210 has also been shown to be associated with the development of different human diseases including various types of cancers, cardiovascular and cerebrovascular diseases, and immunological diseases. Given its multi-faceted functions, miR-210 may serve as a novel and promising theranostic target for prevention and treatment of diseases. Areas covered: This review aims to provide a comprehensive overview of miR-210, the regulation of its expression, biological functions and molecular mechanisms, with particular emphasis on its diagnostic and therapeutic potential. Expert opinion: Although the exact roles of miR-210 in various diseases have not been fully clarified, targeting miR-210 may be a promising therapeutic strategy. Further investigations are also needed to facilitate therapeutic-clinical applications of miR-210 in human diseases.

Cite

CITATION STYLE

APA

Ren, C. X., Leng, R. X., Fan, Y. G., Pan, H. F., Wu, C. H., & Ye, D. Q. (2016, November 1). MicroRNA-210 and its theranostic potential. Expert Opinion on Therapeutic Targets. Taylor and Francis Ltd. https://doi.org/10.1080/14728222.2016.1206890

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free